A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.
Giacchero D, Ramacciotti C, Arnault JP, Brassard M, Baudin E, Maksimovic L, Mateus C, Tomasic G, Wechsler J, Schlumberger M, Robert C.
Giacchero D, et al. Among authors: maksimovic l.
Arch Dermatol. 2012 Dec;148(12):1418-20. doi: 10.1001/2013.jamadermatol.192.
Arch Dermatol. 2012.
PMID: 23247489
Clinical Trial.
No abstract available.